By Bhanvi Satija and Raechel Thankam Job LONDON, July 28 (Reuters) – GSK launched a £1.9 billion ($2.52 billion) cost-savings effort on Tuesday to help fund the British drugmaker's expanded late-stage
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Analysis-AI race redraws Asian air cargo, replacing e-commerce as growth engine
By Julie Zhu and Lisa Baertlein HONG KONG/LOS ANGELES, July 29 (Reuters) - The global…
StanChart lifts income target after wealth boom powers earnings beat; shares jump
By Selena Li and Lawrence White HONG KONG/LONDON, July 29 (Reuters) - Standard Chartered reported…
Michael B Jordan's first look from 'The Thomas Crown Affair' unveiled
Los Angeles [US], July 29 (ANI): The first look of Hollywood star Michael B Jordan's…
